Meeder Asset Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.3K | Buy |
223
+86
| +63% | +$4.01K | ﹤0.01% | 668 |
|
|
2025
Q4 | $4.04K | Sell |
137
-1
| -0.7% | -$27 | ﹤0.01% | 822 |
|
|
2025
Q3 | $3.56K | Buy |
138
+31
| +29% | +$865 | ﹤0.01% | 724 |
|
|
2025
Q2 | $2.95K | Buy |
107
+25
| +30% | +$658 | ﹤0.01% | 779 |
|
|
2025
Q1 | $2.33K | Sell |
82
-30
| -27% | -$1.06K | ﹤0.01% | 858 |
|
|
2024
Q4 | $4.66K | Buy |
112
+12
| +12% | +$574 | ﹤0.01% | 841 |
|
|
2024
Q3 | $6.68K | Buy |
100
+8
| +9% | +$734 | ﹤0.01% | 696 |
|
|
2024
Q2 | $10.9K | Sell |
92
-6
| -6% | -$759 | ﹤0.01% | 632 |
|
|
2024
Q1 | $10.4K | Buy |
+98
| New | +$9.88K | ﹤0.01% | 544 |
|
|
2023
Q1 | – | Sell |
-29,802
| Closed | -$5.35M | – | 758 |
|
|
2022
Q4 | $5.35M | Sell |
29,802
-9,357
| -24% | -$1.53M | 0.47% | 46 |
|
|
2022
Q3 | $4.63M | Buy |
39,159
+9,986
| +34% | +$1.52M | 0.27% | 75 |
|
|
2022
Q2 | $4.17M | Buy |
29,173
+6,268
| +27% | +$896K | 0.24% | 81 |
|
|
2022
Q1 | $3.94M | Buy |
+22,905
| New | +$3.86M | 0.19% | 97 |
|
|
2021
Q4 | – | Sell |
-11,360
| Closed | -$4.37M | – | 1890 |
|
|
2021
Q3 | $4.37M | Sell |
11,360
-15,016
| -57% | -$5.54M | 0.23% | 96 |
|
|
2021
Q2 | $6.2M | Buy |
26,376
+1,437
| +6% | +$257K | 0.29% | 78 |
|
|
2021
Q1 | $3.27M | Buy |
24,939
+24,069
| +2,767% | +$3.49M | 0.17% | 125 |
|
|
2020
Q4 | $91K | Sell |
870
-10,231
| -92% | -$1.04M | 0.02% | 437 |
|
|
2020
Q3 | $785K | Buy |
11,101
+367
| +3% | +$25.6K | 0.05% | 276 |
|
|
2020
Q2 | $690K | Sell |
10,734
-2,924
| -21% | -$160K | 0.04% | 305 |
|
|
2020
Q1 | $409K | Buy |
13,658
+13,531
| +10,654% | +$311K | 0.03% | 384 |
|
|
2019
Q4 | $2K | Buy |
127
+7
| +6% | +$124 | ﹤0.01% | 2028 |
|
|
2019
Q3 | $2K | Buy |
+120
| New | +$1.77K | ﹤0.01% | 1968 |
|
Other funds holding MRNA
VCM
VPM
